Anii K Saxena

  • Citations Per Year
Learn More
The prevalence of anti-HCV antibodies among hemodialysis (HD) patients was studied at King Fahad Hospital, Hofuf, Saudi Arabia. The records of 189 patients undergoing HD were reviewed. The overall prevalence of anti-HCV antibodies was 43.9%. Anti-HCV antibody prevalence was more common among female patients. There was no correlation between repeated blood(More)
BACKGROUND Non-typhoidal Salmonella are one of the key etiological agents of diarrhoeal disease. The appearance of multiple drug resistance along with resistance to quinolones in this bacterium poses a serious therapeutic problem. We determined the prevalence of nalidixic acid and ciprofloxacin resistance in non-typhoidal Salmonella isolated from faecal(More)
BACKGROUND Populations of elderly and type-II diabetics are increasing worldwide. Therefore elderly diabetics on hemodialysis (HD), known to have higher nasal carriage rates, are also increasing. These patients are more often dialyzed through central venous catheters (CVCs). They represent the high-risk groups for Staphylococcus aureus linked vascular(More)
BACKGROUND The necessity of having a vascular access site as well as extracorporeal blood circulation, may add to the risk for patients being dialyzed in units with high HCV prevalence of acquiring hepatitis C virus (HCV) infection. This study endeavors to determine the role the type of vascular access plays in the transmission of HCV infection in the(More)
tective level of anti-HBs (less than 10 mIU/ml) were advised to receive three doses (0, 1, 6 months) of HBV vaccine (each 1 ml dose containing 20 μg hepatitis B surface antigen). The recombinant HBV vaccine Engerix-B (Smith Kline Beecham Biological, Belgium) is provided free of cost by the hospital to all HCW’s. Those who received vaccine their anti-HBs(More)
  • 1